“Rifaximin versus Placebo Preventing the Recurrence of Clinically Overt Hepatic Encephalopathy in Patients having Cirrhosis of Liver”, mfm, vol. 28, no. 12, May 2024, Accessed: Sep. 25, 2025. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/4304